Developing a new device based upon airborne ultrasounds improving diagnosis and follow-up of lung and cardiac diseases.
Developing a new device based upon airborne ultrasounds improving diagnosis and follow-up of lung and cardiac diseases.
What they do: Develop a contactless medical device using airborne ultrasound to screen, diagnose and monitor cardiac and pulmonary pathologies
Headquarters: Paris, France
Founded: 2021
Team size: ~6 employees
Recent funding: Seed round reported €2.5M (July 2025)
Cardiopulmonary diagnosis and monitoring in emergency and acute/chronic care.
2021
MedTech
c2.5M
Round reported to include additional investors such as iXcore, Kima Ventures, Better Angle, Super Capital, Paris Business Angels, Angels Santé and Capital Cell.
Company profile lists a funding-related date in November 2021 but does not state amount details in the available evidence.
“Company completed a Seed round led by institutional investors (Sorbonne Venture by Audacia and Aloe Private Equity) with participation from multiple VC and angel investors, indicating external investor validation.”